Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review

Overview of attention for article published in European Urology, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 15 news outlets
twitter: 86 X users

facebook: 1 Facebook page

Readers on

mendeley: 153 Mendeley

So far, Altmetric has seen 15 news stories from 15 outlets.

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in The Lancet Oncology

FirstWord Pharma, 30 Nov 2020

Nov. 30, 2020 11:00 UTC Novel intravesical gene therapy given once every three months studied in patients with high-grade, BCG-un…

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in The Lancet Oncology

Digital Journal, 30 Nov 2020

CAMBRIDGE, Mass.--(Business Wire)--FerGene Inc., today announced that The Lancet Oncology published the Phase 3 data from the…

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in The Lancet Oncology

MarketScreener, 30 Nov 2020

Novel intravesical gene therapy given once every three months studied in patients with high-grade, BCG-unresponsive non-muscle…

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in The Lancet Oncology

Watertown Public Opinion, 30 Nov 2020

- FerGene Inc., today announced that The Lancet Oncology published the Phase 3 data from the landmark U.S.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 11 additional news stories.